DELIVER Results - Scott D. Solomon, MD

Rate:
N/A
added:
2 years ago
views:
1189
specialty:
Cardiology

Case description

Investigator Scott D. Solomon, MD recaps the results of the DELIVER trial, which found that among individuals with heart failure and a mildly reduced or preserved ejection fraction, dapagliflozin reduced the combined risk of worsening heart failure or cardiovascular death.

tags: deliver trial dapagliflozin


Natalia Dułak
Editor

Natalia Dułak

MD

This user also sharing

Recommended

show more